Christophe Berthoux

Christophe Berthoux is the current CEO at NAMSA. Prior to this, they held various executive positions at companies such as FutureMeds, IAG, IMAGE ANALYSIS GROUP, Citoxlab, and Synexus Clinical Research Ltd. Christophe has over 15 years of experience in the commercial operations of international companies in the healthcare industry. Christophe has a proven track record in developing and executing growth strategies, building high-performing teams, and improving operational efficiencies. Under their leadership, NAMSA has become a leading player in the medical device outsourcing market.

Christophe Berthoux has an executive MBA in management from Purdue University Krannert School of Management and a D.V.M in medicine from Ecole nationale vétérinaire de Lyon.